Global Pet Indus (GLOBALPET)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 24.32% indicates healthy demand and revenue momentum.
• ROCE of 14.73% suggests the business has historically generated acceptable returns on capital.
• Promoter holding of 60.13% aligns management's interests with minority shareholders.
• Latest quarter sales of ₹22 Cr give a base to work from if margins recover.

Concerns

• Profit growth of -109.62% with latest quarter net profit of ₹-0 Cr means the company is currently earning essentially nothing.
• P/E of 36.00 is expensive given collapsing earnings; the PEG ratio is misleading.
• Piotroski F-Score of 4/9 points to weak financial health.
• Insufficient data on book value, ROE, and debt/equity; no dividend paid.

AI Analysis

Let me begin with Graham's test: is this a business I can understand, with earnings power and a margin of safety? Global Pet Indus fails that test today. Top-line growth of 24.32% is attractive, and ROCE of 14.73% suggests capital was once deployed efficiently. But profit growth is -109.62%. The latest quarter shows net profit of ₹-0 Cr, meaning the company is essentially earning nothing. A P/E of 36 on such collapsing earnings is not value; it is hope. The so-called PEG of 1.48 is misleading because it uses a growth rate that did not show up in profits. The Piotroski F-Score of 4/9 tells me financial health is weak. I am also asked to invest without book value, ROE, or debt/equity — to me, insufficient data is itself a reason to wait. There is no dividend, so I receive no compensation for carrying the risk. The one positive is promoter holding of 60.13%, which aligns owners and minority holders. But good intentions do not make earnings. At ₹108, the market cap is ₹133 Cr; I see sales but no earnings. This is not a compounder; it is a turnaround candidate. I need evidence of margin recovery, positive net profit, and a lower price before I act. Until then, this remains on my watch list, not in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer